IL10 and asthma: The observed rise in IL‐10 levels after administering rTS‐SUCLA‐β treatment in mice sensitized with OVA is likely a result of Treg activation induced by this therapy, which corresponds with the upregulation of Treg cells identified through flow cytometry analysis in mice with OVA‐induced asthma as reported in this study.